Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Article
|
Venous Thromboembolism Prophylaxis and Treatment in Patients With Cancer: ASCO Clinical Practice Guideline UpdateJournal of clinical oncology, 2020-02, Vol.38 (5), p.496-520 [Peer Reviewed Journal]ISSN: 0732-183X ;EISSN: 1527-7755 ;DOI: 10.1200/JCO.19.01461 ;PMID: 31381464Full text available |
|
2 |
Material Type: Article
|
Surveillance or Metastasis-Directed Therapy for Oligometastatic Prostate Cancer Recurrence: A Prospective, Randomized, Multicenter Phase II TrialJournal of clinical oncology, 2018-02, Vol.36 (5), p.446-453 [Peer Reviewed Journal]ISSN: 0732-183X ;EISSN: 1527-7755 ;DOI: 10.1200/jco.2017.75.4853 ;PMID: 29240541Full text available |
|
3 |
Material Type: Article
|
CPX-351 (cytarabine and daunorubicin) Liposome for Injection Versus Conventional Cytarabine Plus Daunorubicin in Older Patients With Newly Diagnosed Secondary Acute Myeloid LeukemiaJournal of clinical oncology, 2018-09, Vol.36 (26), p.2684-2692 [Peer Reviewed Journal]2018 by American Society of Clinical Oncology 2018 American Society of Clinical Oncology ;ISSN: 0732-183X ;EISSN: 1527-7755 ;DOI: 10.1200/JCO.2017.77.6112 ;PMID: 30024784Full text available |
|
4 |
Material Type: Article
|
CNS Response to Osimertinib Versus Standard Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Patients With Untreated EGFR-Mutated Advanced Non-Small-Cell Lung CancerJournal of clinical oncology, 2018-11, Vol.36 (33), p.JCO2018783118-3297 [Peer Reviewed Journal]ISSN: 0732-183X ;EISSN: 1527-7755 ;DOI: 10.1200/JCO.2018.78.3118 ;PMID: 30153097Full text available |
|
5 |
Material Type: Article
|
Gefitinib Alone Versus Gefitinib Plus Chemotherapy for Non-Small-Cell Lung Cancer With Mutated Epidermal Growth Factor Receptor: NEJ009 StudyJournal of clinical oncology, 2020-01, Vol.38 (2), p.115-123 [Peer Reviewed Journal]ISSN: 0732-183X ;EISSN: 1527-7755 ;DOI: 10.1200/JCO.19.01488 ;PMID: 31682542Full text available |
|
6 |
Material Type: Article
|
Circulating Tumor DNA Analysis in Patients With Cancer: American Society of Clinical Oncology and College of American Pathologists Joint ReviewJournal of clinical oncology, 2018-06, Vol.36 (16), p.1631-1641 [Peer Reviewed Journal]ISSN: 0732-183X ;EISSN: 1527-7755 ;DOI: 10.1200/JCO.2017.76.8671 ;PMID: 29504847Full text available |
|
7 |
Material Type: Article
|
T Cells Genetically Modified to Express an Anti-B-Cell Maturation Antigen Chimeric Antigen Receptor Cause Remissions of Poor-Prognosis Relapsed Multiple MyelomaJournal of clinical oncology, 2018-08, Vol.36 (22), p.2267-2280 [Peer Reviewed Journal]2018 by American Society of Clinical Oncology 2018 American Society of Clinical Oncology ;ISSN: 0732-183X ;EISSN: 1527-7755 ;DOI: 10.1200/JCO.2018.77.8084 ;PMID: 29812997Full text available |
|
8 |
Material Type: Article
|
SIRveNIB: Selective Internal Radiation Therapy Versus Sorafenib in Asia-Pacific Patients With Hepatocellular CarcinomaJournal of clinical oncology, 2018-07, Vol.36 (19), p.1913-1921 [Peer Reviewed Journal]ISSN: 0732-183X ;EISSN: 1527-7755 ;DOI: 10.1200/JCO.2017.76.0892 ;PMID: 29498924Full text available |
|
9 |
Material Type: Article
|
Overall Survival and Biomarker Analysis of Neoadjuvant Nivolumab Plus Chemotherapy in Operable Stage IIIA Non-Small-Cell Lung Cancer (NADIM phase II trial)Journal of clinical oncology, 2022-09, Vol.40 (25), p.JCO2102660-2933 [Peer Reviewed Journal]2022 by American Society of Clinical Oncology 2022 American Society of Clinical Oncology ;ISSN: 0732-183X ;EISSN: 1527-7755 ;DOI: 10.1200/JCO.21.02660 ;PMID: 35576508Full text available |
|
10 |
Material Type: Article
|
Chemotherapy in Combination With Radiotherapy for Definitive-Intent Treatment of Stage II-IVA Nasopharyngeal Carcinoma: CSCO and ASCO GuidelineJournal of clinical oncology, 2021-03, Vol.39 (7), p.840-859 [Peer Reviewed Journal]ISSN: 0732-183X ;EISSN: 1527-7755 ;DOI: 10.1200/JCO.20.03237 ;PMID: 33405943Full text available |
|
11 |
Material Type: Article
|
Second Revision of the International Staging System (R2-ISS) for Overall Survival in Multiple Myeloma: A European Myeloma Network (EMN) Report Within the HARMONY ProjectJournal of clinical oncology, 2022-10, Vol.40 (29), p.JCO2102614-3418 [Peer Reviewed Journal]ISSN: 0732-183X ;EISSN: 1527-7755 ;DOI: 10.1200/jco.21.02614 ;PMID: 35605179Full text available |
|
12 |
Material Type: Article
|
Gefitinib Versus Gefitinib Plus Pemetrexed and Carboplatin Chemotherapy in EGFR -Mutated Lung CancerJournal of clinical oncology, 2020-01, Vol.38 (2), p.124-136 [Peer Reviewed Journal]ISSN: 0732-183X ;EISSN: 1527-7755 ;DOI: 10.1200/jco.19.01154 ;PMID: 31411950Full text available |
|
13 |
Material Type: Article
|
Pyrotinib or Lapatinib Combined With Capecitabine in HER2-Positive Metastatic Breast Cancer With Prior Taxanes, Anthracyclines, and/or Trastuzumab: A Randomized, Phase II StudyJournal of clinical oncology, 2019-10, Vol.37 (29), p.JCO1900108-2619 [Peer Reviewed Journal]ISSN: 0732-183X ;EISSN: 1527-7755 ;DOI: 10.1200/JCO.19.00108 ;PMID: 31430226Full text available |
|
14 |
Material Type: Article
|
Therapy for Stage IV Non-Small-Cell Lung Cancer With Driver Alterations: ASCO and OH (CCO) Joint Guideline UpdateJournal of clinical oncology, 2021-03, Vol.39 (9), p.1040-1091 [Peer Reviewed Journal]ISSN: 0732-183X ;EISSN: 1527-7755 ;DOI: 10.1200/JCO.20.03570 ;PMID: 33591844Full text available |
|
15 |
Material Type: Article
|
Palbociclib for Residual High-Risk Invasive HR-Positive and HER2-Negative Early Breast Cancer-The Penelope-B TrialJournal of clinical oncology, 2021-05, Vol.39 (14), p.1518-1530 [Peer Reviewed Journal]ISSN: 0732-183X ;EISSN: 1527-7755 ;DOI: 10.1200/JCO.20.03639 ;PMID: 33793299Full text available |
|
16 |
Material Type: Article
|
Neoadjuvant Modified FOLFOX6 With or Without Radiation Versus Fluorouracil Plus Radiation for Locally Advanced Rectal Cancer: Final Results of the Chinese FOWARC TrialJournal of clinical oncology, 2019-12, Vol.37 (34), p.3223-3233 [Peer Reviewed Journal]2019 by American Society of Clinical Oncology 2019 American Society of Clinical Oncology ;ISSN: 0732-183X ;EISSN: 1527-7755 ;DOI: 10.1200/JCO.18.02309 ;PMID: 31557064Full text available |
|
17 |
Material Type: Article
|
SAKK 16/14: Durvalumab in Addition to Neoadjuvant Chemotherapy in Patients With Stage IIIA(N2) Non–Small-Cell Lung Cancer—A Multicenter Single-Arm Phase II TrialJournal of clinical oncology, 2021-09, Vol.39 (26), p.2872-2880 [Peer Reviewed Journal]ISSN: 0732-183X ;EISSN: 1527-7755 ;DOI: 10.1200/JCO.21.00276Full text available |
|
18 |
Material Type: Article
|
Neoadjuvant Chemotherapy Followed by Radical Surgery Versus Concomitant Chemotherapy and Radiotherapy in Patients With Stage IB2, IIA, or IIB Squamous Cervical Cancer: A Randomized Controlled TrialJournal of clinical oncology, 2018-06, Vol.36 (16), p.1548-1555 [Peer Reviewed Journal]ISSN: 0732-183X ;EISSN: 1527-7755 ;DOI: 10.1200/JCO.2017.75.9985 ;PMID: 29432076Full text available |
|
19 |
Material Type: Article
|
Daratumumab, Carfilzomib, Lenalidomide, and Dexamethasone With Minimal Residual Disease Response-Adapted Therapy in Newly Diagnosed Multiple MyelomaJournal of clinical oncology, 2022-09, Vol.40 (25), p.2901-2912 [Peer Reviewed Journal]ISSN: 0732-183X ;EISSN: 1527-7755 ;DOI: 10.1200/JCO.21.01935Full text available |
|
20 |
Material Type: Article
|
Biomarkers for Adjuvant Endocrine and Chemotherapy in Early-Stage Breast Cancer: ASCO Guideline UpdateJournal of clinical oncology, 2022-06, Vol.40 (16), p.1816-1837 [Peer Reviewed Journal]ISSN: 0732-183X ;EISSN: 1527-7755 ;DOI: 10.1200/JCO.22.00069 ;PMID: 35439025Full text available |